Dow Chemical Company’s Xylem XYL Stock Holding History

Dow Chemical Company’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-7,000	Closed	-$274K	–	106
2014 Q2	$274K	Buy	+7,000	New	+$262K	0.02%	89

Other funds holding XYL

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Sasco Capital Fairfield, Connecticut $668M AUM 12.79% 1-Year Est. Return

Dow Chemical Company's XYL Position: Q3 2014 in Review

Dow Chemical Company sold out of Xylem (XYL) in Q3 2014, closing a stake of 7,000 shares — an estimated $274K sold.

Dow Chemical Company first reported a position in XYL in Q2 2014 and held it in 1 quarter. The position peaked at $274K in Q2 2014. 439 funds tracked by Wall St. Rank hold XYL as of Q3 2014.

Dow Chemical Company reported no remaining Xylem position as of Q3 2014 after selling out during the quarter.
Dow Chemical Company sold 7,000 Xylem shares in Q3 2014, an estimated $274K.
Dow Chemical Company first reported a position in Xylem in Q2 2014 and held it in 1 quarter.
Dow Chemical Company's Xylem position peaked at $274K in Q2 2014.
439 funds tracked by Wall St. Rank held Xylem as of Q3 2014.

Based on Dow Chemical Company's 13F filing for Q3 2014, filed 13 Nov 2014.